Introduction NDSRI Quantification at Ultra-Low Levels requires advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies capable of detecting mutagenic impurities at […]
Introduction: Nitrosamine Risk Assessment for Combination Oral Solid Dosage Forms is particularly important when a pharmaceutical product contains two or
Introduction Nitrosamine Leachables Testing is a comprehensive analytical and regulatory process used to evaluate pharmaceutical packaging and drug delivery systems
Nitrosamine Leachables Testing: From Risk Assessment to Confirmatory LC-MS/MS Analysis Read More »
Introduction Nitrosamine Testing for Antidepressants and SSRIs is a specialized analytical and regulatory process designed to detect, quantify, and control
Introduction Headspace GC-MS for Volatile Nitrosamine Analysis is a sophisticated and highly selective analytical technique widely employed to identify and
Introduction Nitrosamine Testing for Antibiotics and Beta-Lactam APIs is a specialized analytical mandate focused on the detection, identification, and quantification
Introduction: Nitrosamine Root Cause Investigation for Sartan APIs has become a defining requirement across pharmaceutical manufacturing following the global recalls
Introduction The critical operational and compliance difference between a nitrosamine screening method and a confirmatory method is primarily defined by
What Is the Difference Between a Nitrosamine Screening Method and a Confirmatory Method? Read More »
Introduction: When comparing ICH M7 vs FDA Nitrosamine Guidance, both share the same objective — protecting patients from potentially carcinogenic
ICH M7 vs. FDA Nitrosamine Guidance: Regulatory Framework Alignment and Key Differences Read More »
Introduction Nitrosamine Testing for Veterinary Drug Products is a critical analytical quality control process used to identify and quantify mutagenic
